Evidence, Causation, and the Ethics of Uncertainty

 Despite its moral force, Chapter 12 raises difficult methodological and ethical questions.

Carson relied on observational studies and case reports that, by modern standards, lacked rigorous controls. Critics argue that correlation does not equal causation—and that Carson occasionally blurred this distinction.

The chapter also highlights a persistent challenge: how much evidence is enough to justify regulation? Acting too early risks overregulation; acting too late risks irreversible harm. Carson clearly favors precaution, but this stance remains contested.

There is also the issue of risk trade-offs. Chemical use has reduced certain diseases and increased food availability. Carson acknowledges this but gives limited attention to weighing benefits against harms.

Some critics contend that Carson’s framing contributed to public anxiety and distrust of science. Others argue that such distrust was a necessary correction to uncritical acceptance.

Yet these critiques must be weighed against historical context. Carson wrote at a time when industry assurances were taken largely at face value, and when affected populations had little voice.

“The Human Price” is not a statistical treatise; it is a moral intervention. Carson forces readers to confront a question that remains unresolved: How much human suffering is acceptable in the name of progress?